Skip to content
Search

Latest Stories

England cricketers will benefit from playing IPL ahead of T20 World Cup: Stokes

The increased participation of English players in the IPL, where there is constant pressure to perform, will benefit them during the T20 World Cup to be held in India later this year, reckons star all-rounder Ben Stokes.

Over the years more and more English players have chosen to take part in the lucrative league. This year, there are 14 England cricketers contracted to play IPL, including white-ball skipper Eoin Morgan Jos Buttler, Stokes, Johnny Bairstow, Moeen Ali, Sam Curran, Tom Curran, Sam Billings, Liam Livingstone and Dawid Malan.


“Yes, the percentage of English players in the IPL has probably grown in the last five or so years,” Stokes, who will turn up for the Rajasthan Royals, told Sky Sports.

“Not only is that great for the individual but it is also great for the players involved in the England set-up; it gives them experience in the most high-profile competition in the world but not only that, you are under constant pressure to perform,” the imposing all-rounder added.

India is set to host the T20 World Cup later this year and Stokes feels it is the perfect opportunity for English players, who were a part of the recently-concluded tour of India, to get more familiar with the Indian conditions.

“You’ve got billions of people watching you and you’ve got the pressure of the franchise on you.

“Being constantly exposed to that is a huge benefit to us as a team, especially with the T20 World Cup coming up at the end of the year in India; it's a great chance for the English guys to get more experience in these conditions,” Stokes said.

After being held in the United Arab Emirates last year due to the COVID-19 pandemic, the IPL returns to India and Stokes hopes fans would be allowed back in the stadiums soon.

“It’s great for the competition that it’s come back to its roots after taking place in Dubai last year, which was an achievement in itself.

“Fingers crossed that fans will be allowed back in at some point during this IPL because they are a huge part of this game and why we play.

“It was an amazing feeling to have fans back in the grounds on our (England’s) recent tour of India - even though 100 per cent of the crowd were against us! Being back in the thick of that atmosphere was amazing!”

The Royals had a disappointing campaign last year, finishing last. However, Stokes is optimistic about the season ahead.

“Last year was obviously disappointing. Yes, we finished bottom of the table but I think it’s not as simple as that. We ebbed and flowed with our performances throughout the season: we had some great ones followed by some pretty poor performances.

“But every year is a clean slate and we are really excited about the prospects of what we are able to do on the field this year,” he added.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less